Court overturns Eli Lilly's $176.5M loss in Teva patent case
US District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing ...
US District Judge Allison Burroughs said in a post-trial ruling that the Teva patents covering the use of antibodies to inhibit headache-causing ...
DOJ had charged seven generic drug makers, including the Israeli giant and Glenmark, with price fixing, bid rigging, and market ...
After heading Moderna's coronavirus vaccine development, Dr. Tal Zaks is ready to tackle new challenges at Israel's Teva Pharmaceuticals.
The Israeli-based pharmaceutical giant has focused on reducing its huge debt load, which stood at $23.2 billion at the end ...
Teva says the Austedo approval was the second approval in China for one of its specialty medicine, adding that it ...
Earlier this year, 44 US states filed a complaint in federal court alleging drug price-fixing by the three pharmaceutical companies ...
Under the deal, Teva admits to no wrongdoing and agrees not to promote opioids in Oklahoma. The company also agrees ...
Funds to be used to fight the opioid crisis in Oklahoma, says state Attorney General Mike Hunter. Under terms of ...
"We take these accusations seriously and we are going to defend ourselves," says Teva Pharmaceutical Industries’ chief financial officer Michael ...
Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers – including Teva Pharmaceuticals USA ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]